Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov record for the completed INCB001158 cancer study is displayed, with detailed study information and supporting documents.SummaryDifference95%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continued to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH announcement banner appears above the ClinicalTrials.gov navigation, describing transition-related terminology updates across NIH content.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation with an access-restricted message. This blocks users from viewing trial details and related documents.SummaryDifference23%

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.